Health Care & Life Sciences » Biotechnology | NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
16,042.00
15,194.00
18,973.00
13,151.00
7,403.00
6,545
Depreciation, Depletion & Amortization
314.00
232.00
164.00
114.00
95.00
266
Other Funds
-
-
-
-
48.00
639
Funds from Operations
13,989.00
15,598.00
19,577.00
8,975.00
4,665.00
6,918
Changes in Working Capital
1,020.00
543.00
1,018.00
3,160.00
1,605.00
1,350
Net Operating Cash Flow
12,969.00
15,055.00
18,559.00
12,135.00
6,270.00
5,568
Capital Expenditures
141.00
68.00
123.00
160.00
244.00
Sale of Fixed Assets & Businesses
-
128.00
37.00
-
-
Purchase/Sale of Investments
1,548.00
2,538.00
-
-
-
Net Investing Cash Flow
1,407.00
2,598.00
86.00
160.00
244.00
Issuance/Reduction of Debt, Net
-
-
1,655.00
1,655.00
-
Net Financing Cash Flow
9,327.00
7,386.00
15,601.00
19,422.00
201.00
Net Change in Cash
2,235.00
5,071.00
3,044.00
7,127.00
6,313.00
Free Cash Flow
13,110.00
15,123.00
18,682.00
12,295.00
6,514.00
Change in Capital Stock
9,327.00
7,386.00
13,946.00
21,077.00
249.00

About NovaBay Pharmaceuticals

View Profile
Address
2000 Powell Street
Emeryville California 94608
United States
Employees -
Website http://novabay.com
Updated 07/08/2019
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in commercializing and developing products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The comapny was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.